Skip to content
Lower risk Medical device recall · FDA · Published September 16, 2019

Becton Dickinson 13 Fr. Trialysis Catheter Recall: Incorrect 12.5cm vs 15cm Length

Becton Dickinson recalls 13 Fr. Trialysis Catheters with incorrect 12.5cm length (instead of 15cm) due to packaging error. Affected units have UDI 00801741066023. No action needed as the error is non-hazardous.

🇺🇸 FDA recall #Z-0285-2020Medical deviceBecton Dickinson ›
Take action

Contact the company

Recalling firmBecton Dickinson & Company1 Becton Dr · Franklin Lakes, NJ 07417-1815
✎ GovInfoNow plain-language explainer

Becton Dickinson is recalling 13 Fr. Trialysis Catheters that were incorrectly packaged with a 12.5cm catheter instead of the required 15cm length. This packaging error does not pose a safety risk to users since the catheter is still functional and the error is non-hazardous. Read more at govinfonow.com/recall/67009-becton-dickinson-13-fr-trialysis-catheter-recall-incorrect-12-5cm.

Source Summary by GovInfoNow · govinfonow.com/recall/67009-becton-dickinson-13-fr-trialysis-catheter-recall-incorrect-12-5cm · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0285-2020

Cite this page

“Becton Dickinson 13 Fr. Trialysis Catheter Recall: Incorrect 12.5cm vs 15cm Length.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/67009-becton-dickinson-13-fr-trialysis-catheter-recall-incorrect-12-5cm. Based on FDA recall #Z-0285-2020 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0285-2020%22&limit=1).

Becton Dickinson & Company voluntarily recalled 13 Fr. Trialysis Catheters with Alphacurve due to incorrect packaging of a 12.5cm catheter instead of the specified 15cm length, according to the FDA. The Food and Drug Administration announced the Class II recall on September 16, 2019.

How to tell if you have it

  • Brand: Becton Dickinson
  • Product: 13 Fr. Trialysis Catheter with Alphacurve
  • Catalog No.: 5653150
  • UDI: 00801741066023 Power-Trialysis Short-Term Alphacurve Dialysis Catheter with a third internal umen for IV therapy, power injection of contrast media, and central venous pressure monitoring.; REDR0440
  • Quantity: 75 units
  • Distribution: Healthcare facilities in AR, FL, IL, NJ, TX, and WI

The hazard

A portion of the lot was incorrectly packaged with a 12.5cm catheter instead of a 15cm catheter.

Context

GovInfoNow's records show Becton Dickinson & Company has 52 other recalls on record since May 31, 2017. Other recent recalls of similar products include Medline Intubation Tray Recall (December 24, 2025) and Medline 14 Fr Suction Catheter Kits Recall (December 24, 2025).

How to tell if you have this one

Check for the UDI code 00801741066023 on the catheter packaging. The product is a 13 Fr. Trialysis Catheter with Alphacurve, Power-Trialysis Short-Term model.

  • Brand
    Becton Dickinson
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Verify Catheter Length

    Check if the catheter is 15cm long; if it's 12.5cm, it's part of the recalled lot.

Where it went and when

Where it was distributed

Distributed in 6 states.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: yesILWisconsin: yesWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: yesNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: yesARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: yesTXFlorida: yesFL

FDA distribution: “Distributed to healthcare facilities in AR, FL, IL, NJ, TX, and WI.” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Arkansas, Florida, Illinois, New Jersey, Texas, Wisconsin.

Recall timeline

FDA terminated this recall 9 months after the firm started it.

1. Firm started the recall: Sep 16, 201912. FDA classified it Class II: Nov 5, 201923. Published in FDA’s Enforcement Report: Nov 13, 201934. FDA terminated the recall: Jun 29, 2020420192020
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0285-2020 (September 16, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0285-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA